胃がん検査・治療・予防の世界市場 2020年

• 英文タイトル：Global Gastric Cancer Testing, Treatment and Prevention Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201115503 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：機械・機器

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、胃がん検査・治療・予防の世界市場を調査対象にし、胃がん検査・治療・予防の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（検査、治療、予防）、用途別分析（病院、診療所、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Biogen Idec、Pacific Edge Diagnostics Nz、Glaxosmithkline Genentech, Inc、Bristol Myers Squibb、Novartis、Eli Lilly And Company、Roche/Genentech Oncolytics、Immunogen Merck & Company、Hoffmann-La Roche Inc.、Pfizer、Zova Biotherapeutics Inc. ・企業別売上、市場シェア ・胃がん検査・治療・予防の地域別市場分析 ・胃がん検査・治療・予防の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・胃がん検査・治療・予防のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・胃がん検査・治療・予防のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・胃がん検査・治療・予防の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・胃がん検査・治療・予防の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・胃がん検査・治療・予防の種類別市場規模2015-2020：検査、治療、予防 ・胃がん検査・治療・予防の用途別市場規模2015-2020：病院、診療所、その他 ・胃がん検査・治療・予防の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Gastric Cancer Testing, Treatment and Prevention market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Gastric Cancer Testing, Treatment and Prevention market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Gastric Cancer Testing, Treatment and Prevention market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Gastric Cancer Testing, Treatment and Prevention market has been segmented into:
Test
Treatment
Prevention

By Application, Gastric Cancer Testing, Treatment and Prevention has been segmented into:
Hospitals
Clinics
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gastric Cancer Testing, Treatment and Prevention market presented in the report. This section sheds light on the sales growth of different regional and country-level Gastric Cancer Testing, Treatment and Prevention markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gastric Cancer Testing, Treatment and Prevention market.

The report offers in-depth assessment of the growth and other aspects of the Gastric Cancer Testing, Treatment and Prevention market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Gastric Cancer Testing, Treatment and Prevention Market Share Analysis
Gastric Cancer Testing, Treatment and Prevention competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Gastric Cancer Testing, Treatment and Prevention sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gastric Cancer Testing, Treatment and Prevention sales, revenue and market share for each player covered in this report.

The major players covered in Gastric Cancer Testing, Treatment and Prevention are:
Biogen Idec
Pacific Edge Diagnostics Nz
Glaxosmithkline Genentech, Inc
Bristol Myers Squibb
Novartis
Eli Lilly And Company
Roche/Genentech Oncolytics
Immunogen Merck & Company
Hoffmann-La Roche Inc.
Pfizer
Zova Biotherapeutics Inc.

レポート目次

---

1 Gastric Cancer Testing, Treatment and Prevention Market Overview
1.1 Product Overview and Scope of Gastric Cancer Testing, Treatment and Prevention
1.2 Classification of Gastric Cancer Testing, Treatment and Prevention by Type
1.2.1 Global Gastric Cancer Testing, Treatment and Prevention Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Type in 2019
1.2.3 Test
1.2.4 Treatment
1.2.5 Prevention
1.3 Global Gastric Cancer Testing, Treatment and Prevention Market by Application
1.3.1 Overview: Global Gastric Cancer Testing, Treatment and Prevention Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Gastric Cancer Testing, Treatment and Prevention Market by Regions
1.4.1 Global Gastric Cancer Testing, Treatment and Prevention Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Gastric Cancer Testing, Treatment and Prevention (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Gastric Cancer Testing, Treatment and Prevention Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Gastric Cancer Testing, Treatment and Prevention Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Gastric Cancer Testing, Treatment and Prevention Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Gastric Cancer Testing, Treatment and Prevention Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Gastric Cancer Testing, Treatment and Prevention Status and Prospect (2015-2025)
2 Company Profiles
2.1 Biogen Idec
2.1.1 Biogen Idec Details
2.1.2 Biogen Idec Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Biogen Idec SWOT Analysis
2.1.4 Biogen Idec Product and Services
2.1.5 Biogen Idec Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pacific Edge Diagnostics Nz
2.2.1 Pacific Edge Diagnostics Nz Details
2.2.2 Pacific Edge Diagnostics Nz Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pacific Edge Diagnostics Nz SWOT Analysis
2.2.4 Pacific Edge Diagnostics Nz Product and Services
2.2.5 Pacific Edge Diagnostics Nz Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2018-2019)
2.3 Glaxosmithkline Genentech, Inc
2.3.1 Glaxosmithkline Genentech, Inc Details
2.3.2 Glaxosmithkline Genentech, Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Glaxosmithkline Genentech, Inc SWOT Analysis
2.3.4 Glaxosmithkline Genentech, Inc Product and Services
2.3.5 Glaxosmithkline Genentech, Inc Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2018-2019)
2.4 Bristol Myers Squibb
2.4.1 Bristol Myers Squibb Details
2.4.2 Bristol Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Bristol Myers Squibb SWOT Analysis
2.4.4 Bristol Myers Squibb Product and Services
2.4.5 Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2018-2019)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Novartis SWOT Analysis
2.5.4 Novartis Product and Services
2.5.5 Novartis Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2018-2019)
2.6 Eli Lilly And Company
2.6.1 Eli Lilly And Company Details
2.6.2 Eli Lilly And Company Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Eli Lilly And Company SWOT Analysis
2.6.4 Eli Lilly And Company Product and Services
2.6.5 Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2018-2019)
2.7 Roche/Genentech Oncolytics
2.7.1 Roche/Genentech Oncolytics Details
2.7.2 Roche/Genentech Oncolytics Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Roche/Genentech Oncolytics SWOT Analysis
2.7.4 Roche/Genentech Oncolytics Product and Services
2.7.5 Roche/Genentech Oncolytics Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2018-2019)
2.8 Immunogen Merck & Company
2.8.1 Immunogen Merck & Company Details
2.8.2 Immunogen Merck & Company Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Immunogen Merck & Company SWOT Analysis
2.8.4 Immunogen Merck & Company Product and Services
2.8.5 Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2018-2019)
2.9 Hoffmann-La Roche Inc.
2.9.1 Hoffmann-La Roche Inc. Details
2.9.2 Hoffmann-La Roche Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Hoffmann-La Roche Inc. SWOT Analysis
2.9.4 Hoffmann-La Roche Inc. Product and Services
2.9.5 Hoffmann-La Roche Inc. Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2018-2019)
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Pfizer SWOT Analysis
2.10.4 Pfizer Product and Services
2.10.5 Pfizer Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2018-2019)
2.11 Zova Biotherapeutics Inc.
2.11.1 Zova Biotherapeutics Inc. Details
2.11.2 Zova Biotherapeutics Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Zova Biotherapeutics Inc. SWOT Analysis
2.11.4 Zova Biotherapeutics Inc. Product and Services
2.11.5 Zova Biotherapeutics Inc. Gastric Cancer Testing, Treatment and Prevention Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Gastric Cancer Testing, Treatment and Prevention Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Gastric Cancer Testing, Treatment and Prevention Players Market Share
3.2.2 Top 10 Gastric Cancer Testing, Treatment and Prevention Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Gastric Cancer Testing, Treatment and Prevention Revenue and Market Share by Regions
4.2 North America Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
4.3 Europe Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
4.5 South America Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
5 North America Gastric Cancer Testing, Treatment and Prevention Revenue by Countries
5.1 North America Gastric Cancer Testing, Treatment and Prevention Revenue by Countries (2015-2020)
5.2 USA Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
5.3 Canada Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
5.4 Mexico Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
6 Europe Gastric Cancer Testing, Treatment and Prevention Revenue by Countries
6.1 Europe Gastric Cancer Testing, Treatment and Prevention Revenue by Countries (2015-2020)
6.2 Germany Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
6.3 UK Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
6.4 France Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
6.5 Russia Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
6.6 Italy Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue by Countries
7.1 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue by Countries (2015-2020)
7.2 China Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
7.3 Japan Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
7.4 Korea Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
7.5 India Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
8 South America Gastric Cancer Testing, Treatment and Prevention Revenue by Countries
8.1 South America Gastric Cancer Testing, Treatment and Prevention Revenue by Countries (2015-2020)
8.2 Brazil Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
8.3 Argentina Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Gastric Cancer Testing, Treatment and Prevention by Countries
9.1 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Revenue by Countries (2015-2020)
9.2 Saudi Arabia Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
9.3 UAE Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
9.4 Egypt Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
9.5 South Africa Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Gastric Cancer Testing, Treatment and Prevention Revenue and Market Share by Type (2015-2020)
10.2 Global Gastric Cancer Testing, Treatment and Prevention Market Forecast by Type (2019-2024)
10.3 Test Revenue Growth Rate (2015-2025)
10.4 Treatment Revenue Growth Rate (2015-2025)
10.5 Prevention Revenue Growth Rate (2015-2025)
11 Global Gastric Cancer Testing, Treatment and Prevention Market Segment by Application
11.1 Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Application (2015-2020)
11.2 Gastric Cancer Testing, Treatment and Prevention Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Other Revenue Growth (2015-2020)
12 Global Gastric Cancer Testing, Treatment and Prevention Market Size Forecast (2021-2025)
12.1 Global Gastric Cancer Testing, Treatment and Prevention Market Size Forecast (2021-2025)
12.2 Global Gastric Cancer Testing, Treatment and Prevention Market Forecast by Regions (2021-2025)
12.3 North America Gastric Cancer Testing, Treatment and Prevention Revenue Market Forecast (2021-2025)
12.4 Europe Gastric Cancer Testing, Treatment and Prevention Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue Market Forecast (2021-2025)
12.6 South America Gastric Cancer Testing, Treatment and Prevention Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Gastric Cancer Testing, Treatment and Prevention Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Gastric Cancer Testing, Treatment and Prevention by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Biogen Idec Corporate Information, Location and Competitors
Table 6. Biogen Idec Gastric Cancer Testing, Treatment and Prevention Major Business
Table 7. Biogen Idec Gastric Cancer Testing, Treatment and Prevention Total Revenue (USD Million) (2017-2018)
Table 8. Biogen Idec SWOT Analysis
Table 9. Biogen Idec Gastric Cancer Testing, Treatment and Prevention Product and Solutions
Table 10. Biogen Idec Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Pacific Edge Diagnostics Nz Corporate Information, Location and Competitors
Table 12. Pacific Edge Diagnostics Nz Gastric Cancer Testing, Treatment and Prevention Major Business
Table 13. Pacific Edge Diagnostics Nz Gastric Cancer Testing, Treatment and Prevention Total Revenue (USD Million) (2018-2019)
Table 14. Pacific Edge Diagnostics Nz SWOT Analysis
Table 15. Pacific Edge Diagnostics Nz Gastric Cancer Testing, Treatment and Prevention Product and Solutions
Table 16. Pacific Edge Diagnostics Nz Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Glaxosmithkline Genentech, Inc Corporate Information, Location and Competitors
Table 18. Glaxosmithkline Genentech, Inc Gastric Cancer Testing, Treatment and Prevention Major Business
Table 19. Glaxosmithkline Genentech, Inc Gastric Cancer Testing, Treatment and Prevention Total Revenue (USD Million) (2017-2018)
Table 20. Glaxosmithkline Genentech, Inc SWOT Analysis
Table 21. Glaxosmithkline Genentech, Inc Gastric Cancer Testing, Treatment and Prevention Product and Solutions
Table 22. Glaxosmithkline Genentech, Inc Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Bristol Myers Squibb Corporate Information, Location and Competitors
Table 24. Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Major Business
Table 25. Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Total Revenue (USD Million) (2017-2018)
Table 26. Bristol Myers Squibb SWOT Analysis
Table 27. Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Product and Solutions
Table 28. Bristol Myers Squibb Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Novartis Corporate Information, Location and Competitors
Table 30. Novartis Gastric Cancer Testing, Treatment and Prevention Major Business
Table 31. Novartis Gastric Cancer Testing, Treatment and Prevention Total Revenue (USD Million) (2017-2018)
Table 32. Novartis SWOT Analysis
Table 33. Novartis Gastric Cancer Testing, Treatment and Prevention Product and Solutions
Table 34. Novartis Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Eli Lilly And Company Corporate Information, Location and Competitors
Table 36. Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Major Business
Table 37. Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Total Revenue (USD Million) (2017-2018)
Table 38. Eli Lilly And Company SWOT Analysis
Table 39. Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Product and Solutions
Table 40. Eli Lilly And Company Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Roche/Genentech Oncolytics Corporate Information, Location and Competitors
Table 42. Roche/Genentech Oncolytics Gastric Cancer Testing, Treatment and Prevention Major Business
Table 43. Roche/Genentech Oncolytics Gastric Cancer Testing, Treatment and Prevention Total Revenue (USD Million) (2017-2018)
Table 44. Roche/Genentech Oncolytics SWOT Analysis
Table 45. Roche/Genentech Oncolytics Gastric Cancer Testing, Treatment and Prevention Product and Solutions
Table 46. Roche/Genentech Oncolytics Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Immunogen Merck & Company Corporate Information, Location and Competitors
Table 48. Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Major Business
Table 49. Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Total Revenue (USD Million) (2017-2018)
Table 50. Immunogen Merck & Company SWOT Analysis
Table 51. Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Product and Solutions
Table 52. Immunogen Merck & Company Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Hoffmann-La Roche Inc. Corporate Information, Location and Competitors
Table 54. Hoffmann-La Roche Inc. Gastric Cancer Testing, Treatment and Prevention Major Business
Table 55. Hoffmann-La Roche Inc. Gastric Cancer Testing, Treatment and Prevention Total Revenue (USD Million) (2017-2018)
Table 56. Hoffmann-La Roche Inc. SWOT Analysis
Table 57. Hoffmann-La Roche Inc. Gastric Cancer Testing, Treatment and Prevention Product and Solutions
Table 58. Hoffmann-La Roche Inc. Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Pfizer Corporate Information, Location and Competitors
Table 60. Pfizer Gastric Cancer Testing, Treatment and Prevention Major Business
Table 61. Pfizer Gastric Cancer Testing, Treatment and Prevention Total Revenue (USD Million) (2017-2018)
Table 62. Pfizer SWOT Analysis
Table 63. Pfizer Gastric Cancer Testing, Treatment and Prevention Product and Solutions
Table 64. Pfizer Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Zova Biotherapeutics Inc. Corporate Information, Location and Competitors
Table 66. Zova Biotherapeutics Inc. Gastric Cancer Testing, Treatment and Prevention Major Business
Table 67. Zova Biotherapeutics Inc. Gastric Cancer Testing, Treatment and Prevention Total Revenue (USD Million) (2017-2018)
Table 68. Zova Biotherapeutics Inc. SWOT Analysis
Table 69. Zova Biotherapeutics Inc. Gastric Cancer Testing, Treatment and Prevention Product and Solutions
Table 70. Zova Biotherapeutics Inc. Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) by Players (2015-2020)
Table 72. Global Gastric Cancer Testing, Treatment and Prevention Revenue Share by Players (2015-2020)
Table 73. Global Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) by Regions (2015-2020)
Table 74. Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Regions (2015-2020)
Table 75. North America Gastric Cancer Testing, Treatment and Prevention Revenue by Countries (2015-2020)
Table 76. North America Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries (2015-2020)
Table 77. Europe Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) by Countries (2015-2020)
Table 79. South America Gastric Cancer Testing, Treatment and Prevention Revenue by Countries (2015-2020)
Table 80. South America Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries (2015-2020)
Table 83. Global Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) by Type (2015-2020)
Table 84. Global Gastric Cancer Testing, Treatment and Prevention Revenue Share by Type (2015-2020)
Table 85. Global Gastric Cancer Testing, Treatment and Prevention Revenue Forecast by Type (2021-2025)
Table 86. Global Gastric Cancer Testing, Treatment and Prevention Revenue by Application (2015-2020)
Table 87. Global Gastric Cancer Testing, Treatment and Prevention Revenue Share by Application (2015-2020)
Table 88. Global Gastric Cancer Testing, Treatment and Prevention Revenue Forecast by Application (2021-2025)
Table 89. Global Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Gastric Cancer Testing, Treatment and Prevention Picture
Figure 2. Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Type in 2019
Figure 3. Test Picture
Figure 4. Treatment Picture
Figure 5. Prevention Picture
Figure 6. Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Clinics Picture
Figure 9. Other Picture
Figure 10. Global Gastric Cancer Testing, Treatment and Prevention Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Gastric Cancer Testing, Treatment and Prevention Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Gastric Cancer Testing, Treatment and Prevention Revenue Market Share in 2019
Figure 19. Global Top 10 Players Gastric Cancer Testing, Treatment and Prevention Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Regions (2015-2020)
Figure 23. Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Regions in 2018
Figure 24. North America Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
Figure 25. Europe Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
Figure 27. South America Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
Figure 29. North America Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries (2015-2020)
Figure 30. North America Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries in 2019
Figure 31. USA Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
Figure 32. Canada Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
Figure 34. Europe Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries in 2019
Figure 36. Germany Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
Figure 37. UK Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
Figure 38. France Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
Figure 39. Russia Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
Figure 40. Italy Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries in 2019
Figure 43. China Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
Figure 44. Japan Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
Figure 45. Korea Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
Figure 46. India Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
Figure 48. South America Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries (2015-2020)
Figure 49. South America Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries in 2019
Figure 50. Brazil Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
Figure 55. UAE Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Gastric Cancer Testing, Treatment and Prevention Revenue and Growth Rate (2015-2020)
Figure 58. Global Gastric Cancer Testing, Treatment and Prevention Revenue Share by Type (2015-2020)
Figure 59. Global Gastric Cancer Testing, Treatment and Prevention Revenue Share by Type in 2019
Figure 60. Global Gastric Cancer Testing, Treatment and Prevention Market Share Forecast by Type (2021-2025)
Figure 61. Global Test Revenue Growth Rate (2015-2020)
Figure 62. Global Treatment Revenue Growth Rate (2015-2020)
Figure 63. Global Prevention Revenue Growth Rate (2015-2020)
Figure 64. Global Gastric Cancer Testing, Treatment and Prevention Revenue Share by Application (2015-2020)
Figure 65. Global Gastric Cancer Testing, Treatment and Prevention Revenue Share by Application in 2019
Figure 66. Global Gastric Cancer Testing, Treatment and Prevention Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 68. Global Clinics Revenue Growth Rate (2015-2020)
Figure 69. Global Other Revenue Growth Rate (2015-2020)
Figure 70. Global Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Gastric Cancer Testing, Treatment and Prevention Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Gastric Cancer Testing, Treatment and Prevention Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Gastric Cancer Testing, Treatment and Prevention Revenue Market Forecast (2021-2025)
Figure 74. Europe Gastric Cancer Testing, Treatment and Prevention Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Gastric Cancer Testing, Treatment and Prevention Revenue Market Forecast (2021-2025)
Figure 76. South America Gastric Cancer Testing, Treatment and Prevention Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Gastric Cancer Testing, Treatment and Prevention Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel

---